Doz

Immune globulin intravenous (IVIG) 10%

ایمونوگلوبولین وریدی (IVIG)

⚠ Unverified

🦠 Antiinfectives For Systemic UseHuman immune globulin

🤰 Pregnancy:Use with caution🤱 Breastfeeding:Use with caution👶 Children:Use with caution👴 Older adults:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (BLA) BLA125105ATC J06BA02

Market / country: 🇺🇸 USA

Gammagard Liquid (US)

🧮 Dose calculator

Primary humoral immunodeficiency · Regimen source: FDA Gammagard Liquid · 2.1, Table 1

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Anaphylaxis or severe hypersensitivity to human immune globulin; IgA deficiency with anti-IgA antibodies and history of hypersensitivity. FDA Gammagard Liquid · 4

Warnings

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label: no animal studies and fetal risk unknown; give only if clearly needed. FDA Gammagard Liquid · 8.1

    “It is not known whether GAMMAGARD LIQUID can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Immune globulins cross the placenta from maternal circulation increasingly after 30 weeks of gestation. GAMMAGARD LIQUID should be given to a pregnant woman only if clearly indicated.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Gammagard Liquid · 8.2

    “Risk Summary There is no information regarding the presence of GAMMAGARD LIQUID in human milk, its effects on the breastfed infant or its effects on milk production.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Gammagard Liquid · 8.4

    “Safety and efficacy of GAMMAGARD LIQUID in pediatric patients below the age of 2 have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Gammagard Liquid · 8.5

    “Infuse at the minimum intravenous infusion rate practicable [see Boxed Warning , Warnings and Precautions (5.2 , 5.4) and Dosage and Administration (2.5) ] .”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav